Celldex Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.44700
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

25.55 1.83 (7.72%)

77.43% Gain from 52W Low

962.6K

XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

6.5 / 100

Technically Neutral

51.4 / 100

1Yr Price target upside is 108%

14 analysts

Celldex Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

77.43% Gain from 52W Low

SWOT Analysis

Celldex Therapeutics Inc Live Price Chart